[August 18, 2016]

Primary Biliary Cirrhosis Market Report - Pipeline Insights 2016 - Research and Markets

Research and Markets has announced the addition of the "Primary Biliary Cirrhosis-Pipeline Insights, 2016" report to their offering.

Primary Biliary Cirrhosis-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Primary Biliary Cirrhosis. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Primary Biliary Cirrhosis.

The report also assesses the Primary Biliary Cirrhosis therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

• The report provides competitive pipeline landscape of Primary Biliary Cirrhosis
• The report rovides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Primary Biliary Cirrhosis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Primary Biliary Cirrhosis and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Overview
• Pipeline Therapeutics
• Therapeutics under Development by Companies
• Filed and Phase III Products
• Comparative Analysis
• Phase II Products
• Comparative Analysis
• Phase I and IND Filed Products
• Comparative Analysis
• Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Discontinued Products
• Dormant Products
• Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/l9rp3v/primary_biliary

Related Topics: Liver and Kidney Disorders Drugs

View source version on businesswire.com: http://www.businesswire.com/news/home/20160818005537/en/

[ Back To TMCnet.com's Homepage ]